Leslie M. Shaw, Ph.D.

faculty photo
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine

Contact information
Hospital of the University of Pennsylvania
7.103 Founders Pavilion 3400 Spruce Street
Philadelphia, PA 19104
Office: (215) 662-6575
Fax: (215) 662-7529
B.S. (Cum Laude, Chemistry)
LeMoyne College, Syracuse, New York, 1962.
Ph.D. (Biochemistry)
S.U.N.Y. at Upstate Medical Center, 1968.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Development, validation and implementation of neurodegenerative diseases biomarkers in cerebrospinal fluid and plasma into treatment trials and clinical studies (eg, ADNI study; PPMI study). These studies include the use of manual and highly automated immunoassays and for amyloid beta(1-42) and for total tau the use of high sensitivity UPLC/tandem mass spectrometry. Multi-modal statistical analyses of these study data to address several questions including the diagnostic utilities of these biomarkers; assessments of the longitudinal trajectories of these biomarkers in AD, MCI and cognitively normal controls to assess the neuropathological changes over time in these individuals.

Description of Clinical Expertise

Measurement and interpretation of the toxicokinetics of drugs and toxins in patients affected by them. Interpretation of the pharmacokinetics of immunosuppressant maintenance medications in transplant patients.

Description of Other Expertise

Development and implementation of mass spectrometry-based methods for measuring small molecules of clinical utility including therapeutic drugs, toxins and special chemistry tests including 25-OH vitamin D.

Selected Publications

Reece J, Milone M, Wang P, Herman D, Petrov D, Shaw LM: A biomarker for concussion: the good, bad and the unknown. J Appl Lab Med (In Press). In Press. DOI: 10.1373/jalm.2019.031187, 2020.

Cousins KAQ, Irwin DJ, Wolk DA, Lee EB, Shaw LM, Trojanowski JQ, Da Re F, Gibbons GS, Grossman M, Phillips JS. : ATN status in amnestic and non-amnestic Alzheimer's Disease and frontotemporal lobar degeneration. Brain 143: 2295-2311, 2020.

Irwin D, Fedler J, Coffey CS, Caspell-Garcia C, Kang J-H, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek K, Trojanowski JQ, Shaw LM. : Evolution of Alzheimer’s disease CSF biomarkers in early Parkinson’s Disease. Ann Neurol 2020 Notes: DOI: 10.1002/ana.25811.

Shaw LM, Korecka M, Figurski M, Toledo J, Irwin D, Kang J-H, Trojanowski JQ. : Detection of Alzheimer disease pathology in patients using biochemical biomarkers: prospects and challenges for use in clinical practice. J Appl Lab Med 2020 - doi:10.1373/jalm.2019.029587 2020.

Korecka M, Figurski MJ, Landau S, Brylska M, Alexander J, Blennow K, Zetterberg H, Jagust W, Trojanowski JQ, Shaw LM for the Alzheimer’s Disease Neuroimaging Initiative: ANALYTICAL AND CLINICAL PERFORMANCE OF AMYLOID BETA PEPTIDES: MEASUREMENT IN CSF OF ADNI2 AND GO PARTICIPANTS BY A LC-MS-MS REFERENCE METHOD. Clin Chem. In Press, 2020.

Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Tronjanowski JQ, Frasier M, Simuni T, Iranzo A, Oertal W, Siderowf A, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Marek K, Galasko D for the PPMI Study.: Longitudunal Analyses of Cerebrospinal Fluid a-Synuclein in Prodromal and Early Parkinson's Disease. Movement Disorders 2019 - In Press Notes: DOI: 10.1002/mds.27806.

Kuhlmann J, Boulo S, Andreaasson U, Bjerke M, Pannee J, Charoud-Got J, Auclair G, Mazoua S, Trapman S, Schimmel H, Emons H, Florian D, Quaglia M, Portelius E, Korecka M, Shaw LM, Lame M, Chambers E, Vanderstitchele H, Stoops E, Leinenbach A, BIttner T, Jenkins RG, Kostanjavecki V, Lewczuk P, Zetterberg H, Zegers I, Blennow K. : The Certification of Amyloid B1-42 in CSF in ERM -DA480/IFCC, ERM - DA481/IFCC and ERM -DA482/IFCC. ERM - European Reference Materials. 2019 In Press.

Shaw LM, Hansson O, Manuilova E, Masters CL, Doecke JD, Li Q-X, Rutz S, Widmann M, Leinenbach A, Blennow K. : Method Comparison study of the Elecsys B-Amyloid (1-42) CSF Assay versus comparator assays and LC-MS/MS. Clinical Biochemistry. May 2019 Notes: https://doi.org/10.1016/j.clinbiochem.2019.05.006.

Lifke V, Kollmorgen G, Manuilova E, Oelschlaegel T, Hillringhaus L, Widmann M, Von Arnim CAF, Otto M, Christenson RH, Powers JL, Shaw LM, Hansson O, Doecke JD, Li Q-B, Teunissen C, Tumani H, Blennow K. : Elecsys Total-Tau and Phospho-Tau (181P) CSF Assays: Analytical performance of the novel, fully automated immunoasays for quantification of tau proteins in human cerebrospinal fluid. Clinical Biochemistry May 2019 Notes: https://doi.org/10.1016/j.clinbiochem.2019.05.005.

Berger M, Oyeyemi D, Olurinde MO, Whitson HE, Weinhold KJ, Woldorff MG, Lipsitz LA, Morett E, Giattino CM, Roberts KC, Zhou J, Bunning T, Ferrandino M, Scheri RP, Cooter M, Chan C, Cabeza R, Browndyke JN, Murdoch DM, Devinney MJ, Shaw LM, Cohen HJ, Mathew JP, and the INTUIT Investigators. : The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction. JAGS (Journal of American Geriatrics Society). 2019 Notes: DOI: 10.1111/jgs.15770.

back to top
Last updated: 08/24/2020
The Trustees of the University of Pennsylvania